| 2024/04/16 20:24:08 | |
|---|---|
| Price | |
| 48.335 USD | |
| Difference | -0.36% (-0.18) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 92,536 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 48.33 USD (1,400) |
| Ask (Ask size) | 48.34 USD (800) |
| Open | 48.45 USD |
| High | 48.60 USD |
| Low | 48.24 USD |
| Close (prev. day) | 48.51 USD |
| VWAP | 48.421159 USD |
| Volume (pcs) | 6,925,331 |
| Trading volume | 335,328,977.59 |
| Number of trades | 68,555 |
| Last size | 100 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/16 20:24:08 | |
|---|---|
| Price | |
| 48.335 USD | |
| Difference | -0.36% (-0.18) |
General attributes
| ISIN | US1101221083 |
| Symbol | BMY |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 92,536 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 48.33 USD (1,400) |
| Ask (Ask size) | 48.34 USD (800) |
| Open | 48.45 USD |
| High | 48.60 USD |
| Low | 48.24 USD |
| Close (prev. day) | 48.51 USD |
| VWAP | 48.421159 USD |
| Volume (pcs) | 6,925,331 |
| Trading volume | 335,328,977.59 |
| Number of trades | 68,555 |
| Last size | 100 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -14.10% | -31.14% | -24.72% |
| Perf (abs.) | -7.96 | -21.94 | -15.93 |
| Beta | 0.62 | 0.45 | 0.31 |
| Volatility | 23.35 | 20.32 | 19.53 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 49.560 USD (11,432,878) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 52.001 USD (17,462,785) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 50.792 USD (15,856,431) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 57.161 USD (12,629,804) |
| YTD High | date | 55.035 USD (2024/03/13) |
| YTD Low | date | 47.580 USD (2024/02/06) |
| 52 Weeks High | date | 70.935 USD (2023/04/25) |
| 52 Weeks Low | date | 47.580 USD (2024/02/06) |
All listings for BRISTOL-MYERS SQUIBB CO.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| BX Swiss | 2024/02/21 | 18:00 | 44.08 CHF | 0.01 | 1 |
| Berlin | 2024/04/16 | 08:05 | 45.64 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/16 | 19:30 | 45.525 EUR | 0.00 | 5 |
| Euronext Milan MTF Global Equity Market | 2024/04/16 | 17:44 | 45.55 EUR | 0.01 | 1 |
| Euronext Milan MTF Trading After Hours | 2024/02/28 | 18:52 | 46.90 EUR | 0.00 | 1 |
| Frankfurt | 2024/04/16 | 16:12 | 45.40 EUR | 0.06 | 4 |
| Hamburg | 2024/04/16 | 08:00 | 46.00 EUR | 0.00 | 1 |
| Hanover | 2024/04/16 | 08:00 | 46.00 EUR | 0.00 | 1 |
| London Stock Exchange European Trade Reporting | 2024/04/16 | 17:30 | 48.5275 USD | 0.05 | 6 |
| Munich | 2024/04/16 | 08:04 | 45.64 EUR | 0.00 | 1 |
| NYSE | 2024/04/16 | 20:24 | 48.335 USD | 335.33 | 68,555 |
| SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
| SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
| Stuttgart | 2024/04/16 | 20:02 | 45.455 EUR | 0.03 | 12 |
| Tradegate | 2024/04/16 | 20:23 | 45.65 EUR | 0.57 | 62 |
| Vienna Stock Exchange | 2024/04/16 | 17:32 | 45.54 EUR | 0.00 | 2 |
| Xetra | 2024/04/16 | 17:35 | 45.58 EUR | 0.17 | 38 |
Company Logo
Contact Details
| BRISTOL MYERS SQUIBB CO. |
| - - |
| Route 206 & Province Line Road - 08543 Princeton |
| Telefon: +1-609-252-4621 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: BRISTOL-MYERS SQUIBB CO. | |
Company Profile
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ. |
Members of Management Board
| Deepak Bhatt | Member of Board of Directors |
| Julia Haller | Member of Board of Directors |
| Karen Vousden | Member of Board of Directors |
| Manuel Hidalgo Medina | Member of Board of Directors |
| Derica Rice | Member of Board of Directors |
| Gerald Storch | Member of Board of Directors |
| Paula Price | Member of Board of Directors |
| Peter Arduini | Member of Board of Directors |
| Phyllis Yale | Member of Board of Directors |
| Theodore Samuels | Member of Board of Directors |
| Giovanni Caforio | Chairman of Managing Board |
| Christopher Boerner | Member of Executive Committee |
| Adam Dubow | Member of Executive Committee |
| Ann M. Powell | Member of Executive Committee |
| Catalina Vargas | Member of Executive Committee |
| David Elkins | Member of Executive Committee |
| Elizabeth A. Mily | Member of Executive Committee |
| Lou Schmukler | Member of Executive Committee |
| Michelle Weese | Member of Executive Committee |
| Paul von Autenried | Member of Executive Committee |
| Rupert Vessey | Member of Executive Committee |
| Samit Hirawat | Member of Executive Committee |
| Sandra Leung | Member of Executive Committee |